Literature DB >> 26080321

Shell disorder, immune evasion and transmission behaviors among human and animal retroviruses.

Gerard Kian-Meng Goh1, A Keith Dunker, Vladimir N Uversky.   

Abstract

This study involves measurements of percentages of intrinsic disorder (PIDs) in the GAG protein shells of various retroviruses. Unique patterns of shell protein disorder can be seen especially when GAG proteins (matrix M, capsid C, and nucleocapsid N) of primate and non-primate retroviruses are compared. HIV-1 presents the most unique pattern of disorder distribution with generally high levels of disorder in all three proteins, while EIAV (PIDs:: 26, 29, 13) is diametrically different from HIV-1 (N C M PIDs: 39.5 ± 3.0, 44.5 ± 2.6, 56.5 ± 10.8). The HTLV viruses (CPID: 32.8 ± 3.4) resemble HIV-2 (C PID: 26.6 ± 2.9) with a moderately disordered capsid. Totally distinct patterns, however, are seen for the non-primate retroviruses. They generally have highly disordered nucleocapsids (PID > 65%) and more ordered outer shells especially the matrix. These characteristics might be attributed to the differences in the way the retroviruses are transmitted, with non-primate viruses having greater non-sexual transmission components such as oral-fecal transmission. These differences are also evolutionarily related to the ways the viruses evade the host immune systems, and thus, have implications for oncolytic virotherapy and animal models in vaccine research. The importance of protein shell disorder in immune evasion, as related to the case of HIV-1, and the difficult search for its vaccines are highlighted.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26080321     DOI: 10.1039/c5mb00277j

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  9 in total

Review 1.  HIV Vaccine Mystery and Viral Shell Disorder.

Authors:  Gerard Kian-Meng Goh; A Keith Dunker; James A Foster; Vladimir N Uversky
Journal:  Biomolecules       Date:  2019-05-08

2.  Zika and Flavivirus Shell Disorder: Virulence and Fetal Morbidity.

Authors:  Gerard Kian-Meng Goh; A Keith Dunker; James A Foster; Vladimir N Uversky
Journal:  Biomolecules       Date:  2019-11-06

Review 3.  On the irrationality of rational design of an HIV vaccine in light of protein intrinsic disorder.

Authors:  Vladimir N Uversky
Journal:  Arch Virol       Date:  2021-02-19       Impact factor: 2.574

4.  Intrinsically-disordered N-termini in human parechovirus 1 capsid proteins bind encapsidated RNA.

Authors:  Shabih Shakeel; James D Evans; Mark Hazelbaker; C Cheng Kao; Robert C Vaughan; Sarah J Butcher
Journal:  Sci Rep       Date:  2018-04-11       Impact factor: 4.379

Review 5.  Leaving no stone unturned in light of the COVID-19 faecal-oral hypothesis? A water, sanitation and hygiene (WASH) perspective targeting low-income countries.

Authors:  Willis Gwenzi
Journal:  Sci Total Environ       Date:  2020-08-20       Impact factor: 7.963

6.  Nipah shell disorder, modes of infection, and virulence.

Authors:  Gerard Kian-Meng Goh; A Keith Dunker; James A Foster; Vladimir N Uversky
Journal:  Microb Pathog       Date:  2020-01-12       Impact factor: 3.738

Review 7.  A Novel Strategy for the Development of Vaccines for SARS-CoV-2 (COVID-19) and Other Viruses Using AI and Viral Shell Disorder.

Authors:  Gerard Kian-Meng Goh; A Keith Dunker; James A Foster; Vladimir N Uversky
Journal:  J Proteome Res       Date:  2020-10-02       Impact factor: 4.466

8.  Shell Disorder Analysis Suggests That Pangolins Offered a Window for a Silent Spread of an Attenuated SARS-CoV-2 Precursor among Humans.

Authors:  Gerard Kian-Meng Goh; A Keith Dunker; James A Foster; Vladimir N Uversky
Journal:  J Proteome Res       Date:  2020-08-27       Impact factor: 4.466

9.  Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids.

Authors:  Gerard Kian-Meng Goh; A Keith Dunker; James A Foster; Vladimir N Uversky
Journal:  Microb Pathog       Date:  2020-03-31       Impact factor: 3.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.